Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation
The present invention provides methods of improving cognitive and motor deficits associated with central nervous system (CNS) disorder or condition in an animal. The methods comprise a general administration of phosphodiesterase 4 inhibitors and optionally training the animal under conditions sufficient to produce an improvement in performance.
1. A method comprising:
administering a phosphodiesterase 4 (PDE4) inhibitor to an animal suffering from a locomotor deficit associated with a traumatic brain injury (TBI);
wherein said inhibitor is administered on at least one day in conjunction with motor training, and
wherein the PDE4 inhibitor is a compound of Formula I:
wherein “Me” means “methyl” and “cPent” means “cyclopentyl” or an enantiomer or a mixture thereof.
2. The method of claim 1 wherein said animal is a human.
3. The method of claim 1 wherein the phosphodiesterase 4 (PDE4) inhibitor comprises the structure:
wherein “Me” means “methyl” and “cPent” means “cyclopentyl”.
4. A method comprising:
providing motor training to an animal suffering from a motor deficit associated with a traumatic brain injury (TBI) in an animal; and
administering a phosphodiesterase 4 (PDE4) inhibitor to said animal;
wherein said inhibitor is administered in conjunction with said motor training and enhances CREB pathway function during said motor training, and
wherein the PDE4 inhibitor is a compound of Formula I:
wherein “Me” means “methyl” and “cPent” means “cyclopentyl” or an enantiomer or a mixture thereof.
5. The method of claim 4 , further comprising the step of training the animal under conditions sufficient to produce an improvement in performance of a particular motor task.
6. The method of claim 5 , wherein a performance gain is achieved relative to the performance of said motor task achieved by training alone.
7. The method of claim 5 , wherein the training comprises multiple training sessions.
8. The method of claim 7 , wherein said phosphodiesterase 4 inhibitor is administered before and during each training session.
9. The method of claim 7 , wherein said phosphodiesterase 4 inhibitor is administered before each training session.
10. The method of claim 7 , wherein the number of training sessions sufficient to produce said improvement in performance is reduced relative to said improvement in performance produced by motor training alone.
11. The method of claim 4 wherein said animal is a human.
12. The method of claim 4 , wherein said providing and administering steps are part of motor rehabilitation that occurs after initial recovery and stabilization of the animal from the TBI.
13. The method of claim 4 wherein the PDE4 inhibitor comprises the structure:
wherein “Me” means “methyl” and “cPent” means “cyclopentyl”.